Trial Profile
IV pharmacokinetics of roflumilast and absolute bioavailability of immediate-release roflumilast tablets in male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Mar 2011
Price :
$35
*
At a glance
- Drugs Roflumilast (Primary) ; Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Takeda Pharmaceuticals International GmbH
- 05 Nov 2010 New trial record.